...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Q4 2017 Events
4
Nov 07, 2017 10:13AM
5
Nov 12, 2017 05:05PM

"IMO there is a Zenith offering coming up"

That sounds like a reasonable expectation, since both the October and November Zenith presentations included on slide 3 "10MM additional shares will be sold shortly."

Share
New Message
Please login to post a reply